Skip to search boxSkip to navigationSkip to main content

Predictors of remission in children with newly diagnosed immune thrombocytopenia: Data from the Intercontinental Cooperative ITP Study Group Registry II participants

  • Carolyn M. Bennett(corresponding author)
    ,
  • Cindy Neunert
    ,
  • Rachael F. Grace
    ,
  • George Buchanan
    ,
  • Paul Imbach
    ,
  • Sara K. Vesely
*Corresponding author for this work
  • Emory University
    ,
  • Columbia University
    ,
  • Dana-Farber Cancer Institute
    ,
  • University of Texas Southwestern Medical Center
    ,
  • University of Basel
    ,
  • University of Oklahoma
Scholary Output:
Contribution to journal
Article
Research
Peer-review

Abstract

<p>Background: Immune thrombocytopenia (ITP) during childhood spontaneously remits in up to 80% of children. Predictors of remission are not well understood. Procedure: We analyzed data from Intercontinental Cooperative ITP Study Group (ICIS) Registry II, a large prospective cohort of children with ITP, to investigate factors that might predict remission. Results: In ICIS Registry II, 705 patients had data collected through 12 months following diagnosis, with 383 patients having data available at 24 months as well. Younger age and pharmacologic treatment at diagnosis were significantly associated with disease resolution at 12 and 24 months (P < 0.0001 for both) as was bleeding at diagnosis (P < 0.0001 and P = 0.0213, respectively). Gender and platelet count at diagnosis were not significantly correlated with remission. In the multivariable analysis, remission at 12 months was associated with younger age, higher bleeding grade at diagnosis, and treatment with a combination of intravenous immunoglobulin (IVIG) and corticosteroids at diagnosis. Only younger age and treatment with IVIG and steroids in combination at diagnosis were associated with remission at 24 months. Patients <1 year of age had the highest odds of achieving remission at both 12 months (OR 4.7, 95% CI: 2.0–10.6) and 24 months (OR 7.0, 95% CI: 2.3–20.8). Conclusions: Younger age, bleeding severity at diagnosis, and initial treatment with a combination of corticosteroids and IVIG are associated with remission at 12 months in the ICIS Registry II. Patients <1 year of age have the highest likelihood of remission. The relationship of bleeding and treatment at diagnosis requires further study to clarify whether these are independent predictors of remission.</p>

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Research
Peer-review

Original language

English (US)

Article number

e26736

Journal (Volume, Issue Number)

Pediatric Blood and Cancer (Volume 65, Issue 1)

Publication milestones

  • Published - 01/2018

Publication status

Published - 01/2018

ISSN

1545-5009

Publication IDs

  • Scopus: 85035072015
  • PubMed: 28792679

Publication metrics

Metrics

Scopus
citations
SciVal
citations
26
SciVal
FWCI
3.23
SciVal
Author count
7
SciVal
Paper percentile
94
SciVal
Top percentile
10
Fractional count
1
Fractional count
0.14
Fractional count
6
Fractional count
0.86
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Citation count
84
Captures
95